Literature DB >> 1472978

Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction.

M J Sumner1, T R Cannon, J W Mundin, D G White, I S Watts.   

Abstract

1. We have investigated the receptors mediating endothelin-induced contraction of rabbit isolated jugular vein (RJV) and rat isolated thoracic aorta (RTA). 2. Endothelin-1 (ET-1) and endothelin-3 (ET-3) contracted RJV preparations with similar potency (EC50 values approximately 1 nM), whereas, ET-1 (EC50:4.5 nM) was approximately 80 fold more potent than ET-3 in contracting RTA. In addition, the ETB receptor-selective agonist [Ala1,3,11,15]ET-1 contracted RJV (EC50:2.1 nM) but not RTA. 3. The ETA receptor antagonist, BQ123, competitively antagonized (pA2 6.93) the contraction of RTA produced by ET-1, but had no effect (at 10 microM) on the contractile effects of either ET-1, ET-3 or [Ala1,3,11,15]ET-1 in RJV. 4. These data suggest that both ETA and ETB receptors can mediate vascular smooth muscle contraction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1472978      PMCID: PMC1907760          DOI: 10.1111/j.1476-5381.1992.tb14537.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor.

Authors:  M Ihara; K Noguchi; T Saeki; T Fukuroda; S Tsuchida; S Kimura; T Fukami; K Ishikawa; M Nishikibe; M Yano
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

2.  Venous smooth muscle contains vasoconstrictor ETB-like receptors.

Authors:  S Moreland; D M McMullen; C L Delaney; V G Lee; J T Hunt
Journal:  Biochem Biophys Res Commun       Date:  1992-04-15       Impact factor: 3.575

3.  An endothelin receptor (ETA) antagonist isolated from Streptomyces misakiensis.

Authors:  M Ihara; T Fukuroda; T Saeki; M Nishikibe; K Kojiri; H Suda; M Yano
Journal:  Biochem Biophys Res Commun       Date:  1991-07-15       Impact factor: 3.575

Review 4.  Molecular and cellular mechanism of endothelin regulation. Implications for vascular function.

Authors:  T Masaki; S Kimura; M Yanagisawa; K Goto
Journal:  Circulation       Date:  1991-10       Impact factor: 29.690

5.  Cloning and expression of a cDNA encoding an endothelin receptor.

Authors:  H Arai; S Hori; I Aramori; H Ohkubo; S Nakanishi
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

6.  Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor.

Authors:  T Sakurai; M Yanagisawa; Y Takuwa; H Miyazaki; S Kimura; K Goto; T Masaki
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

7.  Specific receptors for endothelin-3 in cultured bovine endothelial cells and its cellular mechanism of action.

Authors:  T Emori; Y Hirata; F Marumo
Journal:  FEBS Lett       Date:  1990-04-24       Impact factor: 4.124

8.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

9.  [Ala1,3,11,15]endothelin-1 analogs with ETB agonistic activity.

Authors:  T Saeki; M Ihara; T Fukuroda; M Yamagiwa; M Yano
Journal:  Biochem Biophys Res Commun       Date:  1991-08-30       Impact factor: 3.575

10.  The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes.

Authors:  A Inoue; M Yanagisawa; S Kimura; Y Kasuya; T Miyauchi; K Goto; T Masaki
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

View more
  57 in total

Review 1.  Bosentan and the endothelin system in congestive heart failure.

Authors:  S H Ellahham; V Charlon; Z Abassi; K A Calis; W K Choucair
Journal:  Clin Cardiol       Date:  2000-11       Impact factor: 2.882

Review 2.  Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched?

Authors:  L E Spieker; G Noll; F T Ruschitzka; T F Lüscher
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

3.  Contractile effect of big endothelin-1 and its conversion to endothelin-1 in rabbit cerebral arteries.

Authors:  J Petersson; G C Hanson; B F Lindberg; E D Högestätt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

4.  Evidence for heterogeneity of endothelin receptor distribution in human coronary artery.

Authors:  T Godfraind
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

5.  Evidence for altered vascular responses to exogenous endothelin-1 in patients with advanced cirrhosis with restoration of the normal vasoconstrictor response following successful liver transplantation.

Authors:  R B Vaughan; P W Angus; J P F Chin-Dusting
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

6.  Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.

Authors:  T D Warner; G H Allcock; J R Vane
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

7.  Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation.

Authors:  D D Ivy; J P Kinsella; S H Abman
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

8.  Gene expression of endothelin-1 and endothelin receptor a on monocrotaline-induced pulmonary hypertension in rats after bosentan treatment.

Authors:  Kyoung Ah Lim; Kwan Chang Kim; Min-Sun Cho; Bo En Lee; Hae Soon Kim; Young Mi Hong
Journal:  Korean Circ J       Date:  2010-09-30       Impact factor: 3.243

9.  Endothelin receptor polymorphisms in the cardiovascular system: potential implications for therapy and screening.

Authors:  Luise Holzhauser; Ronald Zolty
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

10.  Activation of native TRPC1/C5/C6 channels by endothelin-1 is mediated by both PIP3 and PIP2 in rabbit coronary artery myocytes.

Authors:  Sohag N Saleh; Anthony P Albert; William A Large
Journal:  J Physiol       Date:  2009-09-21       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.